Skip to main content

NCI SBIR Federal Resources to Accelerate Commercialization (FRAC) Workshop

May 24 – May 26, 2016

NCI Shady Grove Campus Rockville/MD

Add to Outlook Calendar

Event Overview

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center will be hosting an informative workshop on Federal Resources to Accelerate Commercialization (FRAC) on May 24 – 25, 2016 at NCI’s Shady Grove Campus in Rockville, MD. The workshop aims to provide current SBIR/STTR awardees with valuable information and access to both federal and local resources that could ultimately help advance their cancer technologies to the market. In addition to multiple in-depth learning sessions with expert speakers, attendees will have a chance to engage in 1:1 conversations with NCI SBIR Program Directors, as well as speakers including representatives from the FDA, NSF, CDMRP and other NIH funding/resource programs.

The FRAC Workshop is an exclusive event for all current NCI SBIR/STTR awardees (up to 2 attendees per company). Registration is free but attendees are responsible for travel and accommodations expense. Early registration is recommended as 1:1 sessions with organization representatives are offered on first-come-first-serve basis. If you have any questions regarding the FRAC Workshop, please send us an email at NCIsbirEvents@mail.nih.gov.

 
Important Information on Registration

This year we are putting together a program book to help awardee companies learn more about one another to facilitate potential collaboration. The information you provide on the registration form will also be shared with external investors when necessary. Please include information that you are comfortable sharing with third party entities.

Registration deadline is May 5. Register early to secure 1:1 meeting with speakers.

 

FRAC Workshop 2016 Agenda
Day 1 (May 24, 2016)
Time
Session

1:00 PM – 2:00 PM

Welcome & Overview of NCI SBIR Initiatives

2:00 PM – 3:30 PM

Life Science Nation BootCamp: Fundraising & Branding for Translating Federally Funded Research

Panel: Overview of NIH Grants Life Cycle : Hear from Grants Specialists & Scientific Review Officers

3:30 PM – 4:00 PM

Networking Break

4:00 PM – 5:30 PM

NIH Panel: Resources and Collaborative Programs at NIH

(NExT/NCATS/PREVENT/Frederick National Labs)

Life Science Nation BootCamp: Fundraising & Branding for Translating Federally Funded Research

6:00 PM -

Offsite Networking & Meet and Greet (Union Jack's)

Note: Meeting the NCI Program Staff is scheduled for half hour sessions through the day. Sign-up for the meeting is available on the registration page.

 

Day 2 (May 25, 2016)
Time
Session

8:00 AM – 8:30 AM

Check In & Introductions

8:30 AM – 9:00 AM

Opening Remarks on Cancer Centers Program

9:00 AM – 09:45 AM

Panel: Resources to Access Biospecimens and Patient Derived Animal Models

09:45 AM – 10:45 AM

Panel: Sources of non NIH Federal Funding to Advance Your Technology (BARDA/CDMRP/NSF)

10:45 AM – 11:05 AM

Break

11:05 AM – 11:55 PM Panel: Perspectives from FDA CDER
11:05 AM – 11:55 PM

Panel: Perspectives from FDA CDRH (Seminar Room)

12:00 PM – 12:30 PM

CMS and Medicare Coverage Policies for New Medical
Technologies (CMS)

12:30 PM – 2:30 PM

Networking Lunch/1:1 Sessions

2:30 PM – 3:30 PM Panel: Local Resources for Small Businesses (JLabs/Indiana BIO/BioHealth Innovation)
3:30 PM – 4:30 PM Brainstorm Breakout Sessions
4:30 PM – 4:45 PM Closing

 

FRAC Workshop 2016 List of Speakers

 

Organization
Name and Title

National Cancer Institute Office of Cancer Centers

Henry P. Ciolino, PhD
Acting Director
Office of Cancer Centers
National Cancer Institute

Biomedical Advanced Research and Development Authority (BARDA)

Marcy Grace, PhD
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services

National Science Foundation (NSF) SBIR Program

Jesus Soriano, MD, PhD, MBA
Program Director, SBIR/STTR, National Science Foundation

Department of Defense Congressionally Directed Medical Research Programs (DoD CDRMP)

Donna M. Kimbark, Ph.D.
Program Manager
Congressionally Directed Medical Research Programs

Shui-Lin (Stan) Niu, Ph.D.
Science Officer
ARP/BMFRP/PRCRP/SBIR
Congressionally Directed Medical Research Programs

National Center for Advancing Translational Sciences (NCATS)

Lili M. Portilla, MPA
Director, Office of Strategic Alliances
National Center for Advancing Translational Sciences (NCATS), NIH

Nora Yang, PhD
Senior Scientist, Therapeutics for Rare and Neglected Diseases
Director, Portfolio Management and Strategic Operations
Division of Pre-Clinical Innovation
National Center for Advancing Translational Sciences (NCATS), NIH

Krishna “Balki” Balakrishnan, Ph.D., M.B.A.
Senior Technology Transfer Manager
Office of Strategic Alliances
Office of Policy, Communications and Strategic Alliances
Office of the Director
National Center for Advancing Translational Sciences (NCATS), NIH

NCI Experimental Therapeutics (NExT)

Michael J. Difilippantonio, Ph.D.
Program Manager for Therapeutic and Diagnostic Initiatives
Office of the Director, Division of Cancer Treatment & Diagnosis (DCTD)
National Cancer Institute/NIH

Weiwei Chen, PhD
Program Manager
NCI Experimental Therapeutics (NExT) Program
National Cancer Institute/NIH

NCI PREVENT Cancer Preclinical Drug Development Program (PREVENT)

Shizuko Sei, M.D.
Medical Officer & Program Director
Chemopreventive Agent Development Research Group
Division of Cancer Prevention, NCI, NIH
Elizabeth Glaze, PhD, DABT
Program Director
Chemopreventive Agent Development Research Group
Division of Cancer Prevention
National Cancer Institute
NCI Frederick National Laboratory for Cancer Research & RAS initiative Nguyen K. Nguyen, PhD, PMP
Partnership Alliance Manager
Partnership Development Office (PDO)
Frederick National Laboratory for Cancer Research
Andrew Quong, Ph.D.
Director, Partnership Development Office  (PDO)
Frederick National Laboratory for Cancer Research
NCI Frederick National Laboratory for Cancer Research
Center for Advanced Preclinical Research
Sergei Kozlov, PhD, MBA, PMP
Principal Scientist/Team Leader
Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
Zoë Weaver Ohler, PhD
Principal Scientist, Preclinical Evaluation Team Leader
Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
NCI Patient-Derived Xenograft (PDX) Repository Yvonne A. Evrard, Ph.D. [Contractor]
Operations Manager
NCI Patient-Derived Models Repository, Support for DCTD
Frederick National Laboratory for Cancer Research
FDA Center for Drug Evaluation and Research (CDER) Shawna Weis, PhD
Pharmacologist, Office of Hematology and Oncology Products, CDER, FDA
Haw-Jyh (Brian) Chiu, PhD
Toxicologist, Division of Hematology Oncology Toxicology
Center for Drug Evaluation and Research/FDA
Tiffany K. Ricks, PhD
Pharmacologist, Division of Hematology Oncology Toxicology
Office of Hematology and Oncology Products
Center for Drug Evaluation and Research/FDA
Lee Pai-Scherf, MD
Medical Officer, Office of Oncology Drug Products
Center for Drug Evaluation and Research/FDA
FDA Center for Devices and Radiological Health (CDRH) Aaron Schetter, PhD, MPH
Scientific Reviewer
Division of Molecular Genetics and Pathology/OIR
FDA Center for Devices and Radiological Health
Parexel Reem Elbekai, BPharm, PhD, DABT
Senior Consultant, PAREXEL International
Barry S. Sall, RAC, FRAPS
Principal Consultant
PAREXEL Consulting
Ted Carver, Ph.D.
Principal Consultant
PAREXEL International
Generic Devices Consulting

John Greenbaum, BS, MBA
President
Generic Devices Consulting, Inc

Indiana Bio Kristin M. Jones
President and CEO
Indiana Health Industry Forum
J&J Innovation (JLabs) Samantha Lifson
J&J Innovation (JLabs)
BioHealth Innovation Ethan Byler
Managing Director
BioHealth Innovation, Inc.
NCI Biospecimen Resources Lokesh Agrawal, Ph.D.
Program Director
Biorepositories and Biospecimen Research Branch (BBRB)
Cancer Diagnosis Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Life Science Nation Dennis Ford
Founder & CEO
Life Science Nation
Danielle Silva
VP of Business Development
Life Science Nation
Office of Grants Administration Shane Woodward
Branch Chief, Division of Cancer Treatment and Diagnosis
Office of Grants Administration, NCI
NCI SRO

Nadeem Khan, Ph.D.
Scientific Review Officer
Technology Contract Review
Division of Extramural Activities, NCI/NIH

CSR SRO Syed M. Quadri, PH.D.
Chief, Oncology Translational Clinical IRG
Center for Scientific Review, NIH
Office of Acquisition Donna Perry-Lalley, MS, MSM
Contracting Officer, Acting Branch Chief
Prevention, Control and Population Sciences Branch
Office of Acquisitions, NCI
Centers for Medicare & Medicaid Services Marc Harstein
Director
Hospital and Ambulatory Policy Group
Center for Medicare
Centers for Medicare and Medicaid Services
IGI Tech William Plishker, PhD
Co-Founder and CEO
IGI Technologies
ImaginAb Jennifer S. Keppler
Chief Operating Officer
ImaginAb
 
Logistics

Accommodation near the NCI Shady Grove Campus are available at group price in the following facilities:

Day 1 Meet and Greet will be held at Union Jack's.